Insulin-like growth factor I suppresses parathyroid hormone (PTH)/PTH- related protein receptor expression via a mitogen-activated protein kinase pathway in UMR-106 osteoblast-like cells

Endocrinology

Volumn 140, Issue 2, 1999, Pages 871-879

  Kawane, Tetsuya ^a   Horiuchi, Noboru ^a  

^a OHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; BONE GROWTH; BONE REMODELING; CELL PROLIFERATION; ENZYME ACTIVATION; HORMONAL REGULATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; RECEPTOR AFFINITY;

EID: 0032941756     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.2.6517     Document Type: Article

References (49)

1. 1. Humbel RE 1990 Insulin-like growth factors I and II. Eur J Biochem 190:445-462
2. 2. Jones Jl, Clemmons DR 1995 Insulin-like growth factors one! their binding proteins: biological actions. Endocr Rev 16:3-34
3. 3. McCarthy TL, Centrella M, Froesch ER 1989 Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 124:301-309
4. 4. Schmid C, Guler H-P, Rowe D, Canalis E 1989 Insulin-like growth factor ! regulates type 1 procollagen messenger ribonucleic acid steady state levels in bone of rats. Endocrinology 125:1575-1580
5. 5. Hock JM, Centrella M, Canalis E 1988 Insulin-like growth factor I has inde-pendent effects on bone matrix formation and cell replication. Endocrinology 122:254-260
6. 6. Canalis E, Rydziel S, Delany AM, Varghees S, Jeffrey JJ 1995 Insulin-like growth factors inhibit interstitial coilagenase synthesis in bone cell cultures. Endocrinology 136:1348-1354
7. 7. Delany AM, Rydziel S, Canalis E 1996 Automne down-regulation of colla-gcnase-3 in rat bone cell cultures by insulin-like growth factors. Endocrinology 137:4665-4670
8. 8. Ullrich A, Bell JR, Chen EY, Herrera R, Fetruzzelli LM, Dull TJ, Gray A, Coussens L, Liao Y-C, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, Ramachandran J 1985 Human insulin receptor and its relationship to the tyrosine kinase family of oncogcncs. Nature 313:756-760
9. 9. Ullrich A, Gray A, Tarn AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Farncke U, Ramachandran J, Fujita-Yamaguchi Y 1986 Insulin-like growth factor I receptor primary struc-ture: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512
10. 10. Kato H, Faria TN, Stannard B, Roberts CT, LeRoith D 1993 Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-1) receptor. J Biol Chem 268:2655-2661
11. 11. Shemer J, Adamo M, Wilson GL, Heffez D, Zick Y, LeRoith D 1987 Insulin and insulin-like growth factor-! stimulate a common endogenous phospho-protein substrate (pp!85) in intact neuroblastoma cells. J Biol Chem 262:15476-15482
12. 12. Myers Jr MG, Backer JM, Sun X-J, Shoelson S, Hu P, Schlessinger J, Yoakim M, Schaffhausen B, White MF 1992 IRS-1 activates phosphatidylimxsitol 3'-kinase by associating with sri homology 2 domains of p85. Proc Natl Acad Sci USA 89:10350-10354
13. 13. Myers Jr MG, Sun X-J, Cheatham B, Jachna BR, Glasheen EM, Backer JM, White MF 1993 TRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase. Endocrinology 132:1421-1430
14. 14. Pronk GJ, McGIade J, Pelicci G, Pawson T, Bös JL 1993 Insulin-induced phosphorylation of the 46-and 52-kDa She proteins. J Biol Chem 268:5748-5753
15. 15. Rozakis-Âdcock M, McGIade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PC, Schlessinger J, Pawson T 1992 Association of the She and Grb2/Sem5 SH2~containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689-692
16. 16. Baltensperger K, Kozma LM, Cherniack AD, Klarlund JK, Chawla A, Ban-erjee U, Czech MP 1993 Binding of the Ras activator Son of sevcnless to insulin receptor substrate-1 signaling complexes. Science 260:1950-1952
17. 17. Skolnik EY, Batzer A, Li N, Lee C-H, Lowenstein E, Mohammadi M, Mar-golis B, Schlessinger J 1993 The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953-1955
18. 18. Segre GV 1994 Receptors for para thyroid hormone and parathyroid hormone-related protein. In: Bilezikian JP, Marcus R, Levine MA (eds) The Parathyroids. Raven Press, New York, pp 213-229
19. 19 Juppner H, Abou-Samra A-B, Uneno S, Gu W-X, Potts Jr JT, Segre GV 1988 The parathyroid hormone-like peptide associated with humoral hypercalcc-mia of malignancy and parathyroid hormone bind to the same receptor on the plasma membrane of ROS 17/2.8 cells. J Biol Chem 263:8557-8560
20. 20. Fukayama S, Schipani E, Jüppner H, Lanske B, Kronenberg HM, Abou-Samra A-B, Bringhurst FR 1994 Role of protein kinase-A in homologoiis down-regulation of parathyroid hormone (PTH)/PTH-related peptidc recep-tor messenger ribonucleic acid in human osteoblast-like SaOS-2 cells. Endocrinology 134:1851-1858
21. 21. Dunlay R, Hruska K 1990 PTH receptor coupling to phospholipase C is an alternate pathway of signal transduction in bone and kidney. Am J Physio] 258:F223-F231
22. 22 Civitelli R, Fujimori A, Bernier SM, Warlow FM, Goltzman D, Hruska KA, Avioii LV 1992 Heterogeneous intracelkilar free calcium responses to para-thyroid hormone correlate with morphology and receptor distribution in os-teogenic sarcoma cells. Endocrinology 130:2392-2400
23. 23. Partridge NC, Bloch SR, Pearman AT 1994 Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression. J Cell Biochem 55:321-327
24. 24. Canalis E, McCarthy T, Centrelia M 1988 Growth factors and the regulation of bone remodeling. J Clin Invest 81:277-281
25. 25. Goad DL, Tashjian Jr AH 1993 Insulin-like growth factor-I inhibits parathy-roid hormone-stimulated and enhances prostaglandin E2-stimulated adeno-sine 3'J5'-monophosphate production by human osteoblast-Hke SaOS-2 cells. Endocrinology 133:1585-1592
26. 26. Kawane T, Saikatsu S, Akeno N, Abe M, Horiuchi N 1997 Starvation-induced increase in the parathyroid hormone/PTH-related protein receptor mRNA of bone and kidney in sham-operated and thyroparathyroidectomized rats. Eur J Endocrinol 137:273-280
27. 27. Franceschi RT, lyer BS 1992 Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. I Bone Miner Res 7:235-246
28. 28. Guo J, Liu B-Y, Bringhurst FR 1997 Mechanisms of homologous and heter-ologous desensitization of PTH/PTHrP receptor signaling in LLC-PK, cells. Am J Physiol 273:E383-E393
29. 29. Akeno N, Saikatsu S, Kawane T, Horiuchi N 1997 Mouse vitamin O-24-hydroxylasc: molecular cloning, tissue distribution, and transcriptional reg-ulation by lu,25-dihydroxyvitamin Dv Endocrinology 138:2233-2240
30. 30. Kong X-F, Schipani E, Lanske B, Joun H, Karperien M, Defize LHK, Juppner H, Potts JT, Segre GV, Kronenberg HM, Abou-Samra A-B 1994 The rat, mouse and human genes encoding the receptor for parathyroid hormone and parathyroid hormone-related peptide are highly homologous. Biochem Biophys Res Commun 200:1290-1299
31. 31. Huang Z, Fasco MJ, Kaminsky LS 1996 Optimization of DNase I removal of contaminating DNA from RNA for use in quantitative RN'A-PCR. BioTechniques 20:1012-1020
32. 32. Myers Jr MG, Wang L-M, Sun XJ, Zhang YT, Yenush L, Schlessinger J, Pierce JH, White MF 1994 Role of IRS-l-GRB-2 complexes in insulin signaling. Mol Cell Biol 14:3577-3587
33. 33. Skolnik EY, Lee C-H, Batzer A, Vicentini LM, Zhou M, Daly RJ, Myers Jr MJ, Backer JM, Ullrich A, White MF, Schlessinger J 1993 The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated TRS1 and She: implications for insulin control of rus signalling. EMBO J 12:1929-1936
34. 34. Seth A, Gonzalez FA, Gupta S, Raden DL, Davis RJ 1992 Signal transduction within the nucleus by mitogen-activated protein kinase. J Biol Chem 267:24796-24804
35. 35. Clark-Lewis I, Sanghera JS, Pelech SL 1991 Definition of a consensus se-quence for peptide substrate recognition by p44nlpk, the meiosis-activated myelin basic protein kinase. J Biol Chem 266:15180-15184
36. 36 Zandomeni R, Bunick D, Ackerman S, Mittleman B, Wer'nmann R 1983 Mechanism of action of DRB III. Effect on specific in vitro initiation of tran-scription. J Mol Biol 167:561-574
37. 37. Bennett A, Chen T, Feldman D, Hintz RL, Rosenfeld RG 1984 Character-ization of insulin-like growth factor 1 receptor on cultured rat bone cells: regulation of receptor concentration by glucocorticoids. Endocrinology 115:1577-1583
38. 38. Rydziel S, Canalis E 1995 Cortisol represses insulin-like growth factor 11 receptor transcription in skeletal cell cultures. Endocrinology 136:4254-4260
39. 39. Emler CA, Schalch DS 1987 Nutritionally-induced changes in hepatic insuïin-like growth factor I (IGF-I) gene expression in rats. Endocrinology 120:832-834
40. 40. Zhang J, Whitehead Jr RE, Underwood LE 1997 Effect of fasting on insulin-like groivth factor (IGF)-TA and IGF-IB messenger ribonucleic acid and prehor-mones in rat liver. Endocrinology 138:3112-3118
41. 41. McSheehy PMJ, Chambers TJ 1986 Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone résorption. Endocrinology 119:1654-1659
42. 42. Buttice G, Kurkinen M Î993 A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene. ] Biol Chem 268:7196-7204
43. 43. Varghese S, Delany AM, Liang L, Gabbitas B, Jeffrey JJ, Canalis E 1996 Transcriptional and posttranscriptional regulation of interstitial collagenaseby platelet-derived growth factor BB in bone cell cultures. Endocrinology 137:431-437
44. 44. Pang L, SawadaT, Decker SJ, Saltiel AR 1995 Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270:13585-13588
45. 45. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR 1995 PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. ] Biol Chem 270:27489-27494
46. 46. Franke TF, Yang S, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN 1995 The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736
47. 47. Dufoumy B, Alblas J, van Teeffelen HA AM, van Schaik FM A, van der Burg B, Steenbergh PH, Sussenbach JS 1997 Mitogeuic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidyl-inositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem 272:31163-31171
48. 48. Kotani K, Carozzi AJ, Sakaue H, Hara K, Robinson LJ, Clark SF, Yonezawa K, James DE, Kasuga M 1995 Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes. Biochem Biophys Res Commun 209:343-348
49. 49. Dardevet D, Sornet C, Vary T, Grizard J 1996 Phosphatidylinositol 3-kinase and p70 56 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor Ï. Endocrinology 137:4087-409 4